Fiat currencies
Crypto Currencies
No results for ""
We couldn't find anything matching your search.Try again with a different term.
Helius Medical Technologies - Post-IPO
Overview
About Helius Medical Technologies - Post-IPO
Helius Medical Technologies (NASDAQ:HSDT) has announced a major strategic shift with a $500+ million private investment offering to launch a SOL Treasury Company. The oversubscribed PIPE offering, led by Pantera Capital and Summer Capital, includes the sale of common stock at $6.881 and stapled warrants at $10.134, with potential to deliver over $1.25 billion including warrant exercises.
Investors
| Investors | Type | Location | Year Founded | #Portfolio Companies | Email Address | Socials |
|---|---|---|---|---|---|---|
| Fund | United States of America | 2013 | 155 | [email protected] | ||
| Fund | Netherlands | -- | 10 | -- |
Company Profile / Project Introduction
Helius is a leading neurotechnology company in the medical device field, specializing in utilizing non-implantable platform technologies to treat neurological deficits, enhance the brain's compensatory abilities, and promote neuroplasticity, thereby improving the lives of patients with neurological disorders. The company has announced the establishment of the SOL Treasury.